← Every company
Agios Pharmaceuticals Inc Planned Sales
Before an insider at Agios Pharmaceuticals Inc can sell restricted stock they have to file notice of it. This is that notice — the leading edge of the insider trading feed, filed days before the sale it describes.
AGIO insider trades →Notices on file
2
Insiders
1
Shares noticed
2K
permission to sell, not sales
Estimated value
$74.6K
as estimated on filing
Largest notices first
Value is the filer's own estimate of what the sale would raise, at the time they filed.
| Seller | Est. value |
|---|---|
| Gheuens SarahOfficer2026-10-211.5K sh<0.01% | $55.9K |
| Gheuens SarahOfficer2026-10-22500 sh<0.01% | $18.8K |
Source: SEC Form 144 notices, via EDGAR. A notice is permission to sell, not a completed sale — it is often used only in part, or not at all, so none of this is volume and none of it should be added to the insider trading feed. Value is the filer's estimate on the day they filed.
More on AGIO
Company overviewEverything on AGIO in one place, with the price.SEC filingsWhat AGIO's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat AGIO's own officers and directors buy and sell.Who owns itEvery manager reporting a position in AGIO.Funds holding itWhich funds and ETFs hold AGIO, and how big a bet.LobbyingWhat AGIO spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on AGIO's account, and who they worked for.Federal contractsWhat federal agencies pay AGIO.PatentsWhat AGIO is filing at the patent office.